01.002 RWE BS Mar 2022 B (A) 29-03-2022

Real-world evidence in oncology: vitally relevant

Over time oncology practice has seen increased complexity of clinically relevant data recorded for patients, and improved methods of recording (including electronic medical records), which has resulted in increasing volumes of real-world data. Utilising this data has the potential to improve cancer care in many ways including:

  • Help to inform clinical decisions in common settings where the current standard of care, or novel single agents or combinations, are employed in multiple patient populations that are poorly represented in the clinical trials leading to regulatory approval.
  • Updating information regarding potential adverse events on a product approved for clinical use based on demonstrated efficacy, but with a limited number of patients treated when initial regulatory permission was granted.

Click here to learn more.

About SVMPharma

SVMPharma is an innovative strategic consultancy and CRO, with a focus in Real World Evidence (RWE) for pharmaceutical and biotechnology companies. SVMPharma delivers clinical trials within UK and Europe.


DISTILL is a new EDC launched by SVMPharma. As a CRO discover the benefits of DISTILL as part of your service offering and take back control of your clinical trials. DISTILL allows you to develop and manage every aspect of your trials from start to finish. Move away from the restrictions and costs associated with legacy systems.

For more information, please visit and contact us at